Literature DB >> 24366320

Connective tissue diseases. Inhibiting cathepsin S to treat SLE and lupus nephritis.

Nicholas J Bernard.   

Abstract

Entities:  

Year:  2013        PMID： 24366320     DOI： 10.1038/nrrheum.2013.207

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming.

Authors:  Khader Valli Rupanagudi; Onkar P Kulkarni; Julia Lichtnekert; Murthy Narayana Darisipudi; Shrikant R Mulay; Brigitte Schott; Sabine Gruner; Wolfgang Haap; Guido Hartmann; Hans-Joachim Anders
Journal:  Ann Rheum Dis       Date:  2013-12-03       Impact factor: 19.103
  1 in total
  3 in total

Review 1.  Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.

Authors:  Pilar Brito-Zerón; Soledad Retamozo; Hoda Gheitasi; Manuel Ramos-Casals
Journal:  Drugs       Date:  2016-11       Impact factor: 9.546

2.  Cathepsin S inhibition combines control of systemic and peripheral pathomechanisms of autoimmune tissue injury.

Authors:  Maia Tato; Santhosh V Kumar; Yajuan Liu; Shrikant R Mulay; Solange Moll; Bastian Popper; Jonathan N Eberhard; Dana Thomasova; Arne Christian Rufer; Sabine Gruner; Wolfgang Haap; Guido Hartmann; Hans-Joachim Anders
Journal:  Sci Rep       Date:  2017-06-05       Impact factor: 4.379

Review 3.  Targeting lysosomes in human disease: from basic research to clinical applications.

Authors:  Mengdie Cao; Xiangyuan Luo; Kongming Wu; Xingxing He
Journal:  Signal Transduct Target Ther       Date:  2021-11-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.